Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- Check3 days agoChange DetectedThe record presents details of the completed phase II pembrolizumab study for advanced Merkel cell cancer, including eligibility criteria, treatment design, outcomes, locations, investigators, and publications.SummaryDifference63%

- Check10 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2. The study page remains an access-denied error.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH notice announces that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The clinical trial record itself remains inaccessible.SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now shows a 403 Forbidden error with the site header and footer, indicating the study record is temporarily unavailable.SummaryDifference20%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.